The Immunomodulatory Role of Angiocidin, a Novel Angiogenesis Inhibitor

E-ISSN： 1873-4286|15|17|1937-1948

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.17, 2009-06, pp. : 1937-1948

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PI-88: a novel inhibitor of angiogenesis

By Kudchadkar Ragini Gonzalez Rene Lewis Karl D

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1769-1776

Informa Healthcare

Access to resources Recommend Favorite

Novel and selective immunomodulatory drugs

By Lamont A.G.

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. : 299-308

Informa Healthcare

Access to resources Recommend Favorite

Immunomodulatory role of thymulin in lung diseases

By Santos Mário Henriques-Coelho Tiago Leite-Moreira Adelino

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 2, 2010-02 ,pp. : 131-141

Informa Healthcare

Access to resources Recommend Favorite

Novel Aglycones of Steroidal Glycoalkaloids as Potent Tyrosine Kinase Inhibitors: Role in VEGF and EGF Receptors Targeted Angiogenesis

Letters in Drug Design & Discovery, Vol. 8, Iss. 3, 2011-03 ,pp. : 205-215

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Inflammatory Mediators in Angiogenesis

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite